FDA Approved: CARMUSTINE — Original Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved the original ANDA for Carmustine (BiCNU) submitted by Amneal Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms
• Glioblastoma Multiforme
• Hodgkin Lymphoma
• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• BiCNU (Carmustine) (Carmustine)

Snippet

ORIG AP for CARMUSTINE (CARMUSTINE)